Human Genome Epidemiology Literature Finder
|
Records 1 - 16 (of 16 Records) |
| Query Trace: Malaria and CYP2B6[original query] |
|---|
| Prevalence of CYP2B6 alleles in malaria-endemic populations of West Africa and Papua New Guinea. European journal of clinical pharmacology 2006 Apr 62 (4): 267-75. Mehlotra Rajeev K, Ziats Mark N, Bockarie Moses J, Zimmerman Peter |
| Pharmacogenomics of CYP2A6, CYP2B6, CYP2C19, CYP2D6, CYP3A4, CYP3A5 and MDR1 in Vietnam. European journal of clinical pharmacology 2009 Apr 65 (4): 355-63. Veiga M I, Asimus S, Ferreira P E, Martins J P, Cavaco I, Ribeiro V, Hai T N, Petzold M G, Björkman A, Ashton M, Gil J |
| Polymorphism of antimalaria drug metabolizing, nuclear receptor, and drug transport genes among malaria patients in Zanzibar, East Africa. Therapeutic drug monitoring 2008 Feb 30 (1): 10-5. Ferreira Pedro Eduardo, Veiga Maria Isabel, Cavaco Isa, Martins J Paulo, Andersson Björn, Mushin Shaliya, Ali Abullah S, Bhattarai Achuyt, Ribeiro Vera, Björkman Anders, Gil José Ped |
| Effect of single nucleotide polymorphisms in cytochrome P450 isoenzyme and N-acetyltransferase 2 genes on the metabolism of artemisinin-based combination therapies in malaria patients from Cambodia and Tanzania. Antimicrobial agents and chemotherapy 2013 Feb 57 (2): 950-8. Staehli Hodel Eva Maria, Csajka Chantal, Ariey Frédéric, Guidi Monia, Kabanywanyi Abdunoor Mulokozi, Duong Socheat, Decosterd Laurent Arthur, Olliaro Piero, Beck Hans-Peter, Genton Blai |
| Preliminary investigation of the contribution of CYP2A6, CYP2B6, and UGT1A9 polymorphisms on artesunate-mefloquine treatment response in Burmese patients with Plasmodium falciparum malaria. The American journal of tropical medicine and hygiene 2014 Aug 91 (2): 361-6. Phompradit Papichaya, Muhamad Poonuch, Cheoymang Anurak, Na-Bangchang Kesa |
| Cytochrome P450 single nucleotide polymorphisms in an indigenous Tanzanian population: a concern about the metabolism of artemisinin-based combinations. Malaria journal 2014 13 420. Marwa Karol J, Schmidt Theresa, Sjögren Maria, Minzi Omary M S, Kamugisha Erasmus, Swedberg Gö |
| Genetic variability of CYP2B6 polymorphisms in southeast Iranian population: implications for malaria and HIV/AIDS treatment. Archives of Iranian medicine 2014 Oct 17 (10): 685-91. Zakeri Sedigheh, Amiri Nasrin, Pirahmadi Sakineh, Dinparast Djadid Nav |
| CYP2B6*6 genotype and high efavirenz plasma concentration but not nevirapine are associated with low lumefantrine plasma exposure and poor treatment response in HIV-malaria-coinfected patients. The pharmacogenomics journal 2015 May . Maganda B A, Minzi O M S, Ngaimisi E, Kamuhabwa A A R, Aklillu |
| Effect of pharmacogenetics on plasma lumefantrine pharmacokinetics and malaria treatment outcome in pregnant women. Malaria journal 2017 07 16 (1): 267. Mutagonda Ritah F, Kamuhabwa Appolinary A R, Minzi Omary M S, Massawe Siriel N, Asghar Muhammad, Homann Manijeh V, Färnert Anna, Aklillu Ele |
| The Prevalence of CYP2B6 Gene Polymorphisms in Malaria-endemic Population of Timor in East Nusa Tenggara Indonesia. Osong public health and research perspectives 2018 8 9 (4): 192-196. Hananta Linawati, Astuti Indwiani, Sadewa Ahmad Hamim, Alice Josephine, Hutagalung Jontari, Mustof |
| Human cytochrome P450 2B6 genetic variability in Botswana: a case of haplotype diversity and convergent phenotypes. Scientific reports 2018 3 8 (1): 4912. Tawe Leabaneng, Motshoge Thato, Ramatlho Pleasure, Mutukwa Naledi, Muthoga Charles Waithaka, Dongho Ghyslaine Bruna Djeunang, Martinelli Axel, Peloewetse Elias, Russo Gianluca, Quaye Isaac Kweku, Paganotti Giacomo Mar |
| Cytochrome P450 CYP2B6*6 distribution among Congolese individuals with HIV, Tuberculosis and Malaria infection. International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases 2019 Feb . Peko Simon Marie, Gueye Nerly Shirère Gampio, Vouvoungui Christevy, Koukouikila-Koussounda Félix, Kobawila Simon Charles, Nderu David, Velavan Thirumalaisamy P, Ntoumi Franci |
| Differential Impact of Nevirapine on Artemether-Lumefantrine Pharmacokinetics in Individuals Stratified by CYP2B6 c.516G>T Genotypes. Antimicrobial agents and chemotherapy 2019 Dec . Abdullahi Sa'ad T, Soyinka Julius O, Olagunju Adeniyi, Bolarinwa Rahman A, Olarewaju Olusola J, Bakare-Odunola Moji T, Winterberg Markus, Tarning Joel, Owen Andrew, Khoo Sa |
| Influence of selected polymorphisms in disposition genes on lumefantrine pharmacokinetics when coadministered with efavirenz. Pharmacogenetics and genomics 2020 Mar . Adegbola Adebanjo Jonathan, Rana Abutaima, Adeagbo Babatunde Ayodeji, Bolarinwa Rahman A, Olagunju Adeniyi Ebenezer, Siccardi Marco, Owen Andrew, Bolaji Oluseye Oladot |
| The Influence of Cytochrome P450 Polymorphisms on Pharmacokinetic Profiles and Treatment Outcomes Among Malaria Patients in Sub-Saharan Africa: A Systematic Review. Pharmacogenomics and personalized medicine 2023 5 16 449-461. Karol J Marwa, Anthony Kapesa, Erasmus Kamugisha, Göte Swedbe |
| Therapeutic efficacy of generic artemether-lumefantrine in the treatment of uncomplicated malaria in Ghana: assessing anti-malarial efficacy amidst pharmacogenetic variations. Malaria journal 2024 4 23 (1): 125. Nicholas Ekow Thomford, Tracy Kellermann, Robert Peter Biney, Charné Dixon, Samuel Badu Nyarko, Richmond Owusu Ateko, Martins Ekor, George B Ky |
- Page last reviewed:Feb 1, 2024
- Content source: